Sean A. McCarthy
2023
In 2023, Sean A. McCarthy earned a total compensation of $2.6M as Chief Executive Officer and Chairman of the Board of Directors at CytomX Therapeutics, a 13% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $371,899 |
|---|---|
| Option Awards | $533,201 |
| Salary | $652,088 |
| Stock Awards | $1,048,950 |
| Other | $5,000 |
| Total | $2,611,138 |
McCarthy received $1M in stock awards, accounting for 40% of the total pay in 2023.
McCarthy also received $371.9K in non-equity incentive plan, $533.2K in option awards, $652.1K in salary and $5K in other compensation.
Rankings
In 2023, Sean A. McCarthy's compensation ranked 372nd out of 2,983 executives tracked by ExecPay. In other words, McCarthy earned more than 87.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 372 out of 2,983 | 88th |
Division Manufacturing | 211 out of 1,637 | 87th |
Major group Chemicals And Allied Products | 146 out of 906 | 84th |
Industry group Drugs | 143 out of 869 | 84th |
Industry Pharmaceutical Preparations | 87 out of 627 | 86th |
Source: SEC filing on April 4, 2024.
McCarthy's colleagues
We found two more compensation records of executives who worked with Sean A. McCarthy at CytomX Therapeutics in 2023.